«Cancer treatment for transplant patients discovered: Letter notes combination of steroids and immunosuppressants, combined with
immune checkpoint inhibitors helps prevent organ rejection in kidney transplant patients undergoing cancer treatment.»
Not exact matches
BMS's drug, ipilimumab (Yervoy), was the first
checkpoint inhibitor (a kind of cancer immunotherapy drug that essentially
helps the
immune system release its brake and go after tumor cells it might normally miss) to get approved in the US in 2011 for melanoma.
CTLA - 4
inhibitors belong to the family of «
immune checkpoint inhibitors» — a type of immunotherapy that
helps in controlling the body's
immune response to cancer.
PD - 1 / PD - L1
inhibitors belong to the family of «
immune checkpoint inhibitors» — a type of immunotherapy that
helps in controlling the body's
immune response to cancer.